Navigation Links
Millennium Pharmacy Systems, Inc. Appoints New CEO
Date:9/9/2008

WEXFORD, Penn., Sept. 9 /PRNewswire/ -- Millennium Pharmacy Systems, Inc., an industry leader in the provision of technology enabled pharmacy solutions to senior healthcare facilities, announced today the appointment of Richard Scardina as Chief Executive Officer. Mr. Scardina has served on the Millennium Board of Directors since October 2007. Most recently he was self-employed as an independent consultant after serving as an executive with Caremark Rx, Inc.

Gary Duty, a founder of the company, will continue to serve as the company's President and a Director. Mr. Duty commented that, "Mr. Scardina is joining the company at an exciting time as we embark on an expansion plan which will include 8-10 new markets over the next three years. Rich's background and knowledge of organic business growth will be key to our successful deployment in new markets."

Mr. Scardina stated, "Millennium provides the only truly integrated solution offering computerized order entry, automated dispensing, and electronic barcode-based administration of each patient's medications with proven performance across a sizable customer base. It greatly improves patient safety, compliance and nursing efficiency. I am very excited to be joining the company at this time and look forward to working with Gary and the management team as we quickly expand into new markets."

Millennium Pharmacy Systems provides pharmacy and technology services to the long-term care industry including skilled nursing and assisted-living facilities. Its institutional investors include CHL Medical Partners, Boulder Ventures, Essex Woodlands Health Ventures and Ascension Health Ventures.

Visit the Millennium Pharmacy Systems Web site (http://www.mpsrx.com) for more information.


'/>"/>
SOURCE Millennium Pharmacy Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Takeda Completes Acquisition of Millennium
2. Takeda Commences Cash Tender Offer for all Outstanding Shares of Millennium
3. Millennium Expands IBD Franchise with Addition of New Development Candidate
4. Eleventh Annual Lehman Brothers Global Healthcare Conference to Webcast Millennium Presentation
5. Cowen & Company 28th Annual Healthcare Conference to Webcast Millennium Presentation
6. 2008 Susquehanna Healthcare Conference to Webcast Millennium Presentation
7. BIO CEO & Investor 2008 Conference to Webcast Millennium Presentation
8. 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference to Webcast Millennium Presentation
9. Millennium and Harvard Medical School Sign Cooperative Agreement for Research in Novel Field of Cancer Biology
10. Millennium Enters Into $600,000 Product Development Agreement to Fund Product Development for the $20,000,000 Purchase Agreement with Provider Services, Inc.
11. Millennium to Webcast Business Update in Advance of 26th Annual JPMorgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... NY, April 23, 2014Men whose testosterone falls below normal ... to be overweight and have heart disease and type ... identify testosterone-deficient men for further testing and possible treatment ... Men,s Health , a peer-reviewed publication from Mary Ann ... the Journal of Men,s Health website at ...
(Date:4/23/2014)... potential health benefits of probiotics, antioxidants and other nutritional ... the chemical industry is getting in on the action. ... growth, so the industry is responding with clinical research ... story in Chemical & Engineering News (C&EN), ... , Melody M. Bomgardner, a senior editor at C&EN, ...
(Date:4/23/2014)... A team of scientists led by a researcher from ... the National University of Singapore has identified the cancer ... opens up the possibility of developing new drugs for ... cancers. , The research group, led by Dr Chan ... for the first time that a cancer-specific variant of ...
(Date:4/23/2014)... known as Ritalin, may prevent the depletion of self-control, ... a journal of the Association for Psychological Science. , ... or trying to focus attention on a boring textbook ... potential explanation for this difficulty: Exerting self-control for a ... self-control effectively on subsequent tasks. , "It is as ...
(Date:4/22/2014)... the New Jersey Institute of Technology (NJIT) today ... the launch of the New Jersey Innovation Institute ... model for business innovation through the leveraging of ... U.S. Senator Cory Booker, Panasonic Corp. of North ... Lieutenant Governor Kim Guadagno, New Jersey Secretary of ...
Breaking Medicine News(10 mins):Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:ADHD drug may help preserve our self-control resources 2Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2
... York, June 11 XTL,Biopharmaceuticals Ltd. (Nasdaq: XTLB ... General Meeting ("AGM") and Extraordinary General,Meeting ("EGM"). The AGM ... at,the Company,s Israeli offices at Building 3, Kiryat Weizmann ... and 4:30 p.m. Israel time,respectively, on July 17, 2008., ...
... Leaders of the,United American Nurses, AFL-CIO, announced today that ... president of the United States,and will be working to ensure ... look at the candidates and listening to our,staff nurse members ... best,choice to make sure that the needs of staff nurses, ...
... WHAT: Anthony S. Fauci, M.D., director of the National Institute of ... of Health (NIH), will be honored by President George W. ... House ceremony next Thursday, June 19, 2008. , ... his life to expanding the horizons of human knowledge. His ...
... with history of snoring, apnea , , WEDNESDAY, June 11 (HealthDay ... develop a sleep-related breathing disorder, says a University of Virginia ... months to 18 years, who were referred to a pediatric ... had an increased frequency of snoring. , The children,s neck ...
... biological sciences major, earned first place at the ... poster presentation about proteins in the smooth muscle ... The presentation was titled, "Modulation of Cardiovascular Gap ... Tri-Beta is the national biological sciences honor society., ...
... 2008: At least 50% of recent onset rheumatoid arthritis ... symptoms) within 36 weeks when following a systematic approach ... according to results of a study presented today at ... Against Rheumatism in Paris, France. Results of this study ...
Cached Medicine News:Health News:Notification of Annual General Meeting and Extraordinary General Meeting 2Health News:National Staff Nurses Union Endorses Obama for President; UAN Leaders Cite Obama's Commitment to Working Families, Health Care Solutions 2Health News:Children's Neck Size Associated With Sleep Disorders 2Health News:50 percent of recent onset RA patients become free of signs and symptoms within 36 weeks 2
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces ... is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems ... http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
(Date:1/14/2014)... N.J. , Jan. 14, 2014 InformEx, ... and sellers of high-value chemistry, will hold the 30 th ... Miami Beach Convention Center from January 21-24. ... 3,500 attendees from top pharmaceutical, fine chemical and specialty chemical ...
(Date:1/14/2014)...   NuAire , a manufacturer of ergonomically designed laboratory equipment ... of Japan to sell and service ... . NuAire will utilize its network of sales professionals throughout ... to offer assistance in application use, product benefits and features, ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... in AMD patients, LOUISVILLE, Ky., Sept. 29 ... medicines for the treatment,of age-related macular degeneration (AMD) ... has shown early positive safety,results in its Phase ... shuts,down the complement activation cascade that could otherwise ...
... Sept. 26 Indevus Pharmaceuticals,Inc. (Nasdaq: ... signed a development,license and commercialization agreement with ... rights to pagoclone. Indevus previously,announced promising data ... II trial in patients with persistent stuttering ...
Cached Medicine Technology:Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4 2Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 2Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 3Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering 4
... DPX Duo is a SmartBeam platform providing ... measurements of the two most clinical sites ... and at a low radiation dose., ... on Windows, optimizes productivity and ensures consistant ...
... the highly respected single-source CT solution, from ... plaque. With its proprietary STRATON X-ray tube, ... of 0.33s, virtually freezing the hearts motion. ... delivers unprecedented diagnostic detail with up to ...
... Blood Pressure Monitoring System (ABPM) allows health ... blood pressure throughout the day. ABPM therapy ... hypertension and the data generated can be ... compact monitor has sophisticated tracking capabilities to ...
... on Philips' iSyntax technology, which uniquely solves ... image data sets using standard desktop PCs, ... new infrastructure is required. iSite Enterprise delivers ... displayed view, making Philips' image delivery method, ...
Medicine Products: